Medtronic’s Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA’s Muster, Shares Gain
FDA approves Medtronic's Evolut FX+ TAVR system for severe aortic stenosis. Enhanced coronary access, maneuverability for diverse anatomies. Early Commercial Experience in spring 2024.